Article in leMag.sante
The Nice University Hospital is setting up the TABADO program, free support for quitting smoking for more than 15 people enrolled in vocational training.
The managers of the TABADO program from left to right: Prof. Paul Hofman, Melissa Manucci and Taycir Skhiri.
The article is available below in French:
Article in leMag.sante
Assessing the response to treatment, adapting it in the event of resistance, early detection of residual disease predicting a relapse:
These are the major challenges of the innovation with which the Nice University Hospital has equipped itself.
The article is available below in French:
We are very happy to announce that FHU OncoAge participated in the Marathon Nice-Cannes. The event took place on the 28th of November 2021.
This support was given to Aveni and it will contribute to the fight against Covid-19. It will contribute more particularly to the Mucovax project. Mucovax is a nasal spray vaccinaion against the SARS-COV-2 Virus.
You can find more information about Mucovax here.
The development of innovative therapies in cancer, neuromuscular and neurogenetic diseases as well as ageing represents domains with major investments from pharmaceutical companies at the global level within a competitive environment. Hence, patient care, professional practices and regulations move forward rapidly. Given those fast and important changes, this D.U. provides an overview of those therapies to be considered, their application in the 3 main domains including demonstration of common practice, but also a methodological approach to implement innovative therapeutic trials and treatments. The educational team is multidisciplinary and interprofessional on purpose in order to cover the different scopes of interest.
Admission
This training session is accessible to medical professionals (physicians, pharmacists), paramedical hospital staff, trainee physicians or pharmacists, hospital staff such as research or biomedical engineer with practice in a PUI (Pharmacie à usage intérieur) or in a Gene and Cell Therapy Unit (UTCG).
D.U Leader : Prof. Sabrina Sacconi
Inscriptions : 16 August, 2021 – 8 October 2021
Information & contact : inscription.du@chu-nice.fr
2021 IEEE ISBI
AI-BASED APPROACHES TO BIOMEDICAL IMAGE ANALYSIS IN CANCER
Virtual Format : April 13th, 14:00 – 18:15 (CET)
The IEEE International Symposium on Biomedical Imaging (ISBI) is a scientific conference dedicated to mathematical, algorithmic, and computational aspects of biological and biomedical imaging.
The 2021 IEEE ISBI will be fully virtual and will include a Clinical Day on April 13 th, 2021 afternoon from 14:00 to 18:15 (CET). This symposium will feature recent developments in AI BASED APPROACHES TO BIOMEDICAL IMAGE ANALYSIS IN CANCER.
ISBI Clinical Day program includes presentations and a panel discussion among imaging scientists, clinicians, experimental researchers, and industry to foster multi disciplinary interactions.
TOPICS:
CONFIRMED SPEAKERS :
This event, organized as part of the OncoAge UHF and the OptimAge consortium on the theme “Neurodegenerative & neuromuscular diseases and cancer”, brings together researchers from basic and clinical research as well as industrial partners. The aim is to communicate the latest advances and discoveries in the field by internationally renowned teams.
On behalf of the European Society of Pathology (ESP) and the French Society of Pathology we would like to invite you to Nice, France, on the French Riviera Côte d’Azur, to attend the 31st European Congress of Pathology (ECP 2019). ECP 2019 will be held from 7 to 11 September 2019 at the Nice Acropolis Convention Centre located downtown in the heart of Nice. Pathologists and scientists from all over the world are invited to join the 31st ECP and become updated on all aspects of diagnostic and molecular pathology.
The theme for the ECP 2019, is direct and easy to memorize: “Pathology is Nice”. Indeed, in September 2019 Nice will be the capital of European and International pathology where pathologists and their collaborators, molecular biologists, geneticists, bioinformaticians, and information technologists will meet to share advances in our discipline that offers diagnostic, prognostic and predictive information essential for best patient care.
For ECP 2019, the ESP working groups will prepare State-of the Art organ-based sessions while collaborating pathology and clinical scientific societies will interact in joint scientific events. The energetic ESP Trainees’ subcommittee will plan sessions attractive for junior pathologists, while special sessions focusing on advances in molecular pathology, information technology, quality assessment, education, histotechnology and public awareness will complete the diverse programme. Every day, a keynote lecture by distinguished international experts will highlight burning issues in pathology and beyond. We envisage exciting oral free paper and best poster sessions where novel translational research will be presented, while difficulties in the diagnosis of rare disease entities will be discussed in poster sessions.
Attending the 31st ECP will also give you the opportunity to learn more about the capital of the French Riviera, ideally located between the Mediterranean sea and the Alps in a landscape of incomparable natural beauty. Nice is a city of history, culture, art, nature and gastronomy whose maritime scents and earthy flavours will accompany you in every step.
We look forward to welcoming you and share with you a memorable time in charming Nice!
Dina Tiniakos, Greece/UK
President of the European Society of Pathology
Paul Hofman, France
Chair of the Local Organising Committee of ECP 2019
We are very happy to announce that OncoAge has a new office in Pasteur Hospital 1. The inauguration is planned for May 2019.
The new building includes :
This place is located in Nice (South of France), in Hôpital Pasteur 1, Pavillon I. (see the map for location)
This collaborative and pedagogical office will be dedicated to OncoAge teams, and the biobanks team for their meetings and events.
It also will be use for the MSc Biobanks and Complex Data Management during their courses time.
